Join
Live feed
·
INSIDERFilingvia Quantisnow
Aura Biosciences Inc. logo

Chief Technology Officer Plavsic Mark sold $80,244 worth of shares (15,890 units at $5.05), decreasing direct ownership by 8% to 181,397 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AURA· Aura Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AURA (Aura Biosciences Inc.) and more on Quantisnow.